Web-Based COMPASS Program to Support Exercise and Diet in Adults with Stage I-III Pancreatic Cancer Receiving Chemotherapy Before Surgery

What this Trial Is About

Researchers are evaluating a tailored, web-based program called COMPASS designed to support exercise and dietary changes in adults with stage I-III pancreatic cancer who are receiving chemotherapy before surgery. Pancreatic cancer is rare and challenging, and this study aims to provide an accessible program that meets the unique needs of these patients to help maintain physical and mental well-being during treatment. The study focuses on patient engagement and the potential to improve lifestyle habits using this digital platform. Participants are randomly assigned to one of two groups. Both groups receive access to the COMPASS web portal, which offers tailored exercise options including strength, aerobic, balance, and flexibility exercises, along with personalized diet recommendations during their neoadjuvant chemotherapy. Group 1 receives two review sessions and optional motivational text messages three times a week, while Group 2 receives the same intervention plus an additional monthly coaching call. The study monitors adherence and engagement with the portal throughout the chemotherapy period. Participants take part in baseline assessments and follow-up evaluations at three months and upon completing chemotherapy, which may last up to 12 months. Researchers collect data on physical activity, dietary behavior, self-efficacy, quality of life, cognitive function, treatment side effects, and dosing. They also use surveys, focus groups, and web portal usage data to evaluate the programs acceptability and feasibility. The total participation duration aligns with the chemotherapy period, and the study includes ongoing monitoring of symptoms and treatment tolerance.

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy